Fact CheckerSign in

NCT06110468Active, not recruiting

Physical Function, Health and Employment for People With Multiple Sclerosis

Tailored Follow-up for Persons With Multiple Sclerosis to Optimize Physical Functions, Health and Employment: a Prospective Single-blinded Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 21 Nov 2024

Brief summary (registry, in English)

Employment is low in people with MS, even when physical levels of functioning are high. The purpose of this study is to investigate if an individually tailored intervention combining individualized physiotherapy and work adaptation works better than usual care in terms of reducing barriers for work and improving levels of physical activity. The utility of the intervention will be investigated in terms of quality adjusted life years, long-term employment status and work-related costs.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
114 (estimated)
First submitted
24 Oct 2023
Start date
Mar 2024
Primary completion date
Dec 2024
Lead sponsor
Nordlandssykehuset HF
NCT number
NCT06110468

What you commit to

  • Study type: Interventional
  • Planned participants: 114
  • From Mar 2024 to the primary completion date, Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Exacerbation of symptoms (i.e. relapse) within two weeks prior to enrolment.

Other illness

  • Other serious conditions.

Other

  • Pregnancy at enrolment.

Who the study is looking for

  • Diagnosed with Multiple Sclerosis according to the McDonald's criteria
  • Extended Disability Status Scale (EDSS) 0-4
  • Being employed, part time or full time, may include various degrees of sick leave, disability pension or AAP.
  • Living in the participating 18 municipalities (Hammerfest, Alta, Senja, Målselv, Tromsø, Harstad, Narvik, Fauske, Bodø, Meløy, Vågan, Vestvågøy, Sortland, Hadsel, Rana, Vefsn, Alstadhaug, Brønnøy).

Age in the registry: 18 years to 67 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nordlandssykehuset HF
Coordinator of this site? Confirm its status
BodøNorwayUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.